Resistin is a pro-inflammatory adipokine (in humans produced mainly by macrophages/immune cells rather than adipocytes).
Levels are elevated in obesity, insulin resistance, and chronic inflammation.
In cancer biology, resistin is predominantly pro-tumorigenic, especially via inflammatory and metabolic reprogramming pathways.
Resistin is functionally upregulated in cancer and acts as a:
-Pro-inflammatory amplifier
-Metabolic dysregulator
-EMT and metastasis promoter
Its strongest relevance is in obesity- and inflammation-associated cancers, where it cooperates with leptin and insulin signaling while opposing irisin and adiponectin.
|